Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
about
Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching.Annual banned-substance review: analytical approaches in human sports drug testing.Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).Applying SWATH Mass Spectrometry to Investigate Human Cervicovaginal Fluid During the Menstrual Cycle.Compound identification in forensic toxicological analysis with untargeted LC-MS-based techniques.Validation of an ELISA Synthetic Cannabinoids Urine AssaySWATH-MS as a tool for biomarker discovery - from basic research to clinical applications.In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.The Changing Face of Recreational Drug Use.Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes.Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.High-resolution mass spectrometry in toxicology: current status and future perspectives.SWATH acquisition mode for drug metabolism and metabolomics investigations.How Safe Is Safe for Marine Toxins Monitoring?A tutorial in small molecule identification via electrospray ionization-mass spectrometry: The practical art of structural elucidation.Comparison of Post-targeted and Pre-targeted Urine Drug Screening by UHPLC-HR-QTOFMS.UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.Qualitative and quantitative temporal analysis of licit and illicit drugs in wastewater in Australia using liquid chromatography coupled to mass spectrometry.A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds.Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.Automated screening of reversed-phase stationary phases for small-molecule separations using liquid chromatography with mass spectrometry.
P2860
Q30244676-0162F146-BFA5-4A0C-AD7D-6D58B434F0BEQ34474547-F9B1E432-E1C3-46F9-BE63-FEE4DF223226Q34509038-A35A167A-7E4B-4643-8930-4DE54034B9B6Q34519359-88AB9FCF-603A-4D82-B304-8893ABB23777Q34553148-5CD334D0-81C1-4230-B722-87C507D8BEFCQ35673557-1D26CF55-89B6-4DC1-805E-C61199816177Q35840290-9511EBA4-3219-43EF-B2E5-453FC0B13000Q35981647-D47781BE-8B5D-4147-B53C-27E1C331D482Q36262132-8D55A88A-D658-4308-A259-369CCAC415E8Q36653901-484626C4-AC0A-4920-BC1D-249ED42FE102Q36950560-A0BE818D-F9BF-416E-90F5-DE7AFF65D13FQ37078847-7CCFC3E1-2278-4697-8A94-51A324CABE47Q37146958-869C6E32-C951-4984-BA18-BF4CBEF007B7Q38734612-63C218CA-EEFC-4F4D-98DF-8A1145BD1CA0Q38846184-B9A3EB10-0941-46BA-B5A5-AC7C08FE995BQ39557300-425F4A8F-78B2-43AE-B998-3F4CAEAA838EQ42211221-61858FAA-8208-4F8E-B839-D8C42CF9F70FQ47614283-9707A2FD-D9C9-4411-B02F-BF92E3F41D87Q48032412-07771244-31BF-4C9D-A256-CD701756B708Q48220900-C9A0D5B6-97BF-4BD7-BC1E-CF5A1DFB46ADQ48578302-56F1B6B9-0E8C-4917-8781-12944CFCD828Q50062799-91CB7D8B-E957-4327-818B-D1EB3F4BC733Q52815923-58EF29F0-AC38-434B-A270-61CFE71C4163Q53740167-87505469-A846-4CDE-954A-F43B6292DBAB
P2860
Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@ast
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@en
type
label
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@ast
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@en
prefLabel
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@ast
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@en
P2860
P1476
Nontargeted SWATH acquisition ...... tion tandem mass spectrometry.
@en
P2093
Karl B Scheidweiler
Michael J Y Jarvis
P2860
P2888
P304
P356
10.1007/S00216-014-8118-8
P407
P577
2014-09-16T00:00:00Z